Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

Patient-Centered Customized Psychosocial Adherence Enhancement Intervention Schizophrenia (CAE-S) Study

I'm Interested!

Prospective 12-week randomized controlled trial (RCT) of remotely- delivered Customized Adherence Enhancement for poorly adherent individuals with schizophrenia (CAE-S) vs Enhanced Treatment as Usual (eTAU)

  • Sex at Birth: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Behavioral
  • Trial Phase: NA
  • Conditions Being Studied:

Study Purpose

The purpose of the study is to see if a behavioral intervention helps people who have schizophrenia take their medication more consistently and better manage their symptoms. Participating is the study lasts about 3 months and includes 3 study visits and 6 educational session visits. All visits can be done via video conferencing and compensation is provided.

Who Can Participate

Participants 18 years or older diagnosed with schizophrenia may be eligible for this study.

Principal Investigator
Martha Sajatovic MD
Department/Division
Psychiatry (MHRP)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

  • UH IRB: STUDY20230135
  • StudyID: 2022-01101
  • ClinicalTrials.gov: N/A
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422